• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STIMWAVE TECHNOLOGIES INC. FREEDOM NEUROSTIMULATOR; SPINAL CORD STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STIMWAVE TECHNOLOGIES INC. FREEDOM NEUROSTIMULATOR; SPINAL CORD STIMULATOR Back to Search Results
Model Number FR8A-RCV-A0, FR8A-SPR-B0
Device Problem Migration (4003)
Patient Problem Erosion (1750)
Event Type  Injury  
Manufacturer Narrative
Complaint-(b)(4)was reported to stimwave on october 2, 2019, and verified to be the same stimulator complaint through comparing stimulator serial number sections on issue-1507 (complaint-(b)(4)) and issue-253 (complaint-(b)(4)).Complaint-(b)(4)was captured in capa-(b)(4) as being reportable and requiring remediation.In complaint-(b)(4), the patient reported the same skin irritation caused by migration.At that time, no intervention was required, although the migration causing skin irritation does run the risk of erosion leading to potential infection.On (b)(6) 2020, the patient contacted the cr reporting that one of stimulators has migrated and is now visibly seen under the skin near the patient's groin.The patient was unable to provide any further information about the issue as she was not able to go to a hospital due to the covid-19 restrictions.On (b)(6) 2020, the cr reported that the patient still has both stimulators implanted and is scheduled for an appointment with the implanting clinician to discuss doing and explant.Patient mentioned that she was not having great therapy since the migration occurred.Patient does continue to activate the stimulators for intermittent relief after high activity.On (b)(6) 2020, the cr reported that it was unknown which of the two fr8a stimulators had migrated.Cr also reported that patient had been active prior to and post migration issue.On (b)(6) 2020, the cr reported that the patient had a revision done on the stimulator that had migrated.The cr reported that the patient was not reprogrammed and was doing well post revision.No further issues have been reported.
 
Event Description
Stimwave quality has investigated the details for a reported skin irritation caused by migration, submitted to the stimwave complaint system on (b)(6) 2020, by clinical representative (cr), in (b)(6).Cr became aware of this issue (b)(6) 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREEDOM NEUROSTIMULATOR
Type of Device
SPINAL CORD STIMULATOR
Manufacturer (Section D)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach,
Manufacturer (Section G)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach,
Manufacturer Contact
luis fontaneda
1310 park central boulevard s.
pompano beach, 
MDR Report Key10160228
MDR Text Key196152845
Report Number3010676138-2020-00053
Device Sequence Number1
Product Code GZB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170141
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Biomedical Engineer
Type of Report Initial
Report Date 05/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2020
Is this an Adverse Event Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/01/2020
Device Model NumberFR8A-RCV-A0, FR8A-SPR-B0
Device Lot NumberSWO171024, SWO180215
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/14/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/07/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
-
-